Results 1 to 10 of about 47,555 (149)
The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries. [PDF]
PLoS ONE, 2017 Advances in pharmaceuticals offer improved health outcomes for a wide range of illnesses, yet medicines are often inaccessible for many patients worldwide.
Steven G Morgan +2 more
doaj +4 more sources
Journal of Pharmaceutical Policy and Practice, 2023 Background The local manufacture of pharmaceuticals is an opportunity to develop a broader manufacturing and knowledge-based economy and reduce over dependence on imports.
Kalidi Rajab +8 more
doaj +1 more source
Health Policy Open, 2021 Free Trade Agreements (FTA) are controversial for threatening essential aspects of health, especially access to affordable medicines. The US-Peru FTA required changes in the Peruvian pharmaceutical legislation that resulted in the implementation of the ...
Lita Araujo +2 more
doaj +1 more source
Just Rules for Innovative Pharmaceuticals
Philosophies, 2022 Globalized in 1995 through the TRIPs Agreement, humanity’s dominant mechanism for encouraging innovations involves 20-year product patents, whose monopoly features enable innovators to reap large markups or licensing fees from early users.
Thomas Pogge
doaj +1 more source
The Role of Taxing Financial-Economic Performance on Companies in the Pharmaceutical Sector [PDF]
Annals of Dunarea de Jos University. Fascicle I : Economics and Applied Informatics, 2020 In order to determine the impact taxation has on the financial-economic performances, we must strongly consider the determination relations of the financial performance indexes based on the profit and loss account.
Mihaela Cristina ONICA
doaj +1 more source
Frontiers in Public Health, 2023 To implement state policies of zero-markup drug policy and medical service fee adjustment for public hospitals, this study constructed game models of the pharmaceutical supply chain, consisting of a drug supplier and a public hospital. The study obtained
Nan Zhou +5 more
doaj +1 more source
Discrepancies in Open Access Fees within Pharmacology, Toxicology, and Pharmaceutics Journals
Advanced Pharmaceutical Bulletin, 2023 Modern science has been transformed by open access (OA) publishing levied a significant economic burden on the authors. This article analyzes the discrepancies among OA publication fees in pharmacology, toxicology, and pharmaceutics. The observations comprise 160 OA journals and their corresponding Q ranking, SJR, H index, impact factor, country, and ...
Rana M.F. Sammour, Aliasgar Shahiwala
openaire +3 more sources
A systematic review of pharmaceutical price mark-up practice and its implementation
Exploratory Research in Clinical and Social Pharmacy, 2021 Pharmaceutical products, apart from being essential for medical treatment, are of high value and heavily regulated to ensure the prices are controlled.
Kah Seng Lee +3 more
doaj +1 more source
Study of Ukrainian price market of medicines for scalp seborrheic dermatitis treatment
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2018 Considering mostly long time use of medicines by the patients with scalp seborrheic dermatitis (SSD) the social-economical availability of medications with antiseborrheic activity becomes important and the price of medicine appear as a certain measure.
V. А. Solodovnyk +2 more
doaj +1 more source
Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues.
PLoS ONE, 2021 ObjectivesCollection and storage of biospecimens and data for biobanking raise many ethical concerns. Stakeholders' opinions about these ethical issues are important since they can help in the development of ethical guidelines to govern biobanking ...
Ahmed Samir Abdelhafiz +4 more
doaj +1 more source